This comprehensive bundle of CME courses aims to equip osteopathic family physicians with medical updates and an overview of addiction and substance use disorders, including substances such as opioids, alcohol, nicotine, and marijuana. Additionally, safe prescribing practices for benzodiazepine medications will be discussed, along with proper tapering regimens and best practices for the use of stimulant medications, including benefits and clinical use, will be explored. Learners will become familiar with available medications for different substance use disorders in clinical settings. The roles of peer recovery support specialists and their networks will be discussed, along with practical training on the use of Narcan (naloxone) for overdose prevention and education.
Curated from across conferences and webinars held over the past three years, this collection allows you to select individual sessions or take a deep dive by purchasing all of this content at once. Each session is individually accredited and will be reported to AOA within 6-8 weeks of completion of the attestation.
The DEA has outlined how DEA-registrants can meet the new requirements. As an accredited organization named in section 1263 of CAA 2023, ACOFP has bundled these courses together to provide physicians with a series that may satisfy all or portions of your DEA training requirements. For specific information regarding state licensing requirements, please contact the state licensing board directly.
If you see a green icon next to a session it is signifying you already have access to this course as part of participating in another ACOFP conference, consider just purchasing the additional resources available by clicking directly though to their source on the individual sessions.
This course bundle of CME is discounted at $199 for ACOFP members and $275 for non-members. Interested in becoming a member and saving on CME while joining your family of family physicians? Join here.